10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
In the realm of antibiotic research, the pursuit of new therapeutic avenues and the optimization of existing antibiotics are paramount. The evolution of resistance mechanisms in bacteria continually challenges the efficacy of antibiotics, necessitating innovative strategies to overcome this hurdle. Researchers are exploring various avenues such as combination therapies, antibiotic adjuvants, and bacteriophage therapy to enhance the effectiveness of antibiotics and prolong their lifespan. Moreover, efforts to discover new antibiotic classes with unique mechanisms of action are ongoing, fueled by advances in genomics, structural biology, and synthetic chemistry. Collaborative initiatives between academia, industry, and regulatory bodies are vital to accelerate the translation of promising research findings into clinical applications, ensuring that effective antibiotics remain a cornerstone of modern medicine for years to come.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria